LEADER 05329nam  2200769Ia 450 
001 9910961837603321
005 20251017110142.0
010   $a0-309-16898-8
010   $a1-280-18311-X
010   $a9786610183111
010   $a0-309-56635-5
035   $a(CKB)111069351129710
035   $a(EBL)3377275
035   $a(SSID)ssj0000242312
035   $a(PQKBManifestationID)11215415
035   $a(PQKBTitleCode)TC0000242312
035   $a(PQKBWorkID)10310779
035   $a(PQKB)11254893
035   $a(MiAaPQ)EBC3377275
035   $a(Au-PeEL)EBL3377275
035   $a(CaPaEBR)ebr10068523
035   $a(OCoLC)923269330
035   $a(DNLM)1166710
035   $a(BIP)53857752
035   $a(BIP)7987868
035   $a(EXLCZ)99111069351129710
100   $a20021120d2002      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aScientific and policy considerations in developing smallpox vaccination options $ea workshop summary /$fBoard on Health Promotion and Disease Prevention, Institute of Medicine of the National Academies
205   $a1st ed.
210   $aWashington, D.C. $cNational Academy Press$dc2002
215   $a1 online resource (57 p.)
300   $aThis report summarizes the discussions of [a] meeting, held on June 15, 2002 in Washington, D.C.
311 08$a0-309-08604-3 
320   $aIncludes bibliographical references.
327   $a""SCIENTIFIC AND POLICY CONSIDERATIONS IN DEVELOPING SMALLPOX VACCINATION OPTIONS""; ""Copyright""; ""INDEPENDENT REPORT REVIEWERS""; ""Contents""; ""INTRODUCTION""; ""OPENING REMARKS""; ""SCIENTIFIC BACKGROUND ON SMALLPOX AND SMALLPOX VACCINATION""; ""SMALLPOX DISEASE""; ""SMALLPOX CONTROL STRATEGIES AND VACCINE AVAILABILITY""; ""SMALLPOX VACCINATION: EFFICACY, AVAILABILITY, DURATION OF IMMUNITY, AND TIMING""; ""SMALLPOX VACCINATION SAFETY""; ""CDC-ACIP SMALLPOX VACCINATION POLICY REVIEW""; ""CDCa???S DRAFT POLICY OPTIONS""; ""SUMMARY OF REGIONAL MEETINGS""
327   $a""THE MODELING BASIS FOR VACCINATION POLICY OPTIONS""""MODEL 1""; ""MODEL 2""; ""MODEL 3""; ""SOVIET OUTBREAK OF SMALLPOX""; ""LESSONS LEARNED FROM RAPID MOBILIZATION FOR ANTHRAX MASS PROPHYLAXIS: IMPLICATIONS FOR SMALLPOX""; ""DISTRICT OF COLUMBIA""; ""ARLINGTON COUNTY, VIRGINIA""; ""MARYLAND""; ""EMERGENCY RESPONDERS""; ""EMERGENCY MEDICAL TECHNICIANS""; ""FIRE CHIEFS""; ""EMERGENCY SERVICES""; ""HEALTH CARE PROVIDERS""; ""NURSES""; ""EMERGENCY ROOM PHYSICIANS""; ""FAMILY PHYSICIANS""; ""PEDIATRICIANS""; ""HOSPITAL WORKERS""; ""HOSPITAL SYSTEMS""; ""SPECIAL POPULATIONS""
327   $a""ETHICAL, LEGAL, AND SOCIAL ISSUES""""ETHICAL CONSIDERATIONS""; ""INDEMNIFICATION FOR ADVERSE EVENTS""; ""COMMUNICATION""; ""RISK COMMUNICATION""; ""PUBLIC HEALTH RISKS AND BENEFITS""; ""PERSPECTIVE 1""; ""PERSPECTIVE 2""; ""PERSPECTIVE 3""; ""PERSPECTIVE 4""; ""PUBLIC COMMENTS AND DISCUSSION""; ""USE OF SCARCE PUBLIC HEALTH RESOURCES AND INSURING DUAL USE APPROACHES""; ""VACCINE DEVELOPMENT AND APPROVAL""; ""INTERNATIONAL CONSIDERATIONS""; ""UNCERTAINTIES""; ""COMMUNICATION AND EDUCATION""; ""EPILOGUE""
327   $a""DRAFT SUPPLEMENTAL RECOMMENDATIONS OF THE ACIP USE OF SMALLPOX (VACCINIA) VACCINE, JUNE 2002""""PRE-RELEASE VACCINATION OF THE GENERAL POPULATION""; ""PRE-RELEASE VACCINATION OF SELECTED GROUPS TO ENHANCE SMALLPOX RESPONSE READINESS""; ""Smallpox Response Teams""; ""Designated Smallpox Healthcare Personnel at Designated Hospitals""; ""Implementation of Recommendations""
330   $aAt the World Health Assembly in May 1980, the World Health Organization declared the world free of smallpox. Smallpox vaccination of civilians is now indicated only for laboratory workers directly involved with smallpox or closely related orthopox viruses. However recent questions raised by the terrorist attacks in fall 2001 have renewed concerns about possible outbreaks of smallpox resulting from its use as a biological weapon. In June 2002, the Institute of Medicine convened a public conference to discuss the scientific, clinical, procedural, and administrative aspects of various immunization strategies. Scientific and Policy Considerations in Developing Smallpox Vaccination Options summarizes the presentations and discussions from this workshop.
517 3 $aDeveloping smallpox vaccination
606   $aSmallpox$xVaccination
606   $aSmallpox vaccine
606   $aBiological warfare
606   $aEmergency medical services$zUnited States
606   $aMedical policy$zUnited States
606   $aPublic health$zUnited States
615  0$aSmallpox$xVaccination.
615  0$aSmallpox vaccine.
615  0$aBiological warfare.
615  0$aEmergency medical services
615  0$aMedical policy
615  0$aPublic health
676   $a614.5
712 02$aInstitute of Medicine (U.S.).$bCommittee for a Forum on Smallpox: The Scientific Basis for Vaccination Policy Options.
712 02$aInstitute of Medicine (U.S.).$bBoard on Health Promotion and Disease Prevention.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910961837603321
996   $aScientific and policy considerations in developing smallpox vaccination options$94447674
997   $aUNINA